AIMC Topic: Trimethoprim, Sulfamethoxazole Drug Combination

Clear Filters Showing 1 to 2 of 2 articles

Innovative strategies against superbugs: Developing an AI-CDSS for precise Stenotrophomonas maltophilia treatment.

Journal of global antimicrobial resistance Jun 22, 2024
OBJECTIVES: The World Health Organization named Stenotrophomonas maltophilia (SM) a critical multi-drug resistant threat, necessitating rapid diagnostic strategies. Traditional culturing methods require up to 96 h, including 72 h for bacterial growth...
Humans Artificial Intelligence Machine Learning Anti-Bacterial Agents Microbial Sensitivity Tests Drug Resistance, Multiple, Bacterial Decision Support Systems, Clinical Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Gram-Negative Bacterial Infections Levofloxacin Trimethoprim, Sulfamethoxazole Drug Combination Stenotrophomonas maltophilia
View on PubMed DOI

Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.

The Journal of infectious diseases Oct 25, 2016
BACKGROUND:  Cotrimoxazole (CTX) discontinuation increases malaria incidence in human immunodeficiency virus (HIV)-infected individuals. Rates, quantity, and timing of parasitemia rebound following CTX remain undefined.
Humans Female Adult Male Prevalence HIV Infections Anti-HIV Agents Medication Adherence Plasmodium falciparum Malaria Antimalarials Polymerase Chain Reaction Kenya Parasite Load Parasitemia Trimethoprim, Sulfamethoxazole Drug Combination
View on PubMed DOI
Popular Topics
Recent Journals